CMND stock has given up its prior gain. Clearmind Medicine shares were trading higher after the company announced an update based on their "hands-on" experience from the CMND-100 trial.

Benzinga Newsdesk www.benzinga.com Positive 94.4%

Neg 0% Neu 0% Pos 94.4%

Comments

No comments yet. Be the first!